International Journal of Medical and All Body Health Research  |  e-ISSN: 2582-8940  |  Double-Blind Peer Review  |  Open Access  |  CC BY-NC-SA 4.0

Current Issues
     2026:7/4

International Journal of Medical and All Body Health Research

e-ISSN: 2582-8940 | Open Access

Probiotic Use in Gastrointestinal (G.I.T.) Infections

Dr. Pradyuman Kaushik, Dr. J Srinivas, Dr. Rati Saxena, Dr. Prashant Jr

Department of Microbiology, Raj Shree Medical College, Bareilly, Uttar Pradesh, India; Dr. KNS Memorial Institute of Medical Sciences, Barabanki, Uttar, India

Article Information

Volume / Issue7 / 3 (July-August 2026)
Pages61-65
AccessOpen Access

Publication Timeline

  • Received11 May 2026
  • Accepted09 June 2026
  • Published

Full Text (PDF)

Open Access - Free to Download

Download Full Article (PDF) JATS XML

Abstract

Probiotics — live microorganisms that, when administered in adequate amounts, confer a health benefit on the host — have been widely investigated as adjunctive or stand-alone therapy for gastrointestinal (GIT) infections. This narrative review synthesises evidence from systematic reviews, meta-analyses, large randomised controlled trials, and clinical guidelines on probiotic use in acute infectious diarrhoea, antibiotic-associated diarrhoea (AAD), Clostridioides difficile-associated diarrhoea (CDAD), Helicobacter pylori infection, and traveller's diarrhoea. Relevant literature was identified through PubMed, the Cochrane Library, and Google Scholar. Pooled evidence indicates that selected strains — particularly Lactobacillus rhamnosus GG and Saccharomyces boulardii — can reduce the duration and severity of acute diarrhoea and lower the incidence of AAD and CDAD, while multi-strain formulations modestly improve H. pylori eradication rates and reduce therapy-related adverse effects. However, an updated 2020 Cochrane review and two large paediatric emergency-department trials have tempered earlier optimism, underscoring strain specificity, dosing, timing, and publication bias as major sources of heterogeneity. Probiotic supplementation appears safe in immunocompetent populations and offers measurable, though strain- and indication-dependent, benefit, supporting cautious, evidence-guided clinical use.

Keywords

ProbioticsGastrointestinal infectionsDiarrhoeaLactobacillus rhamnosus GGSaccharomyces boulardiiClostridioides difficile

References

  1. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506-14. [Google Scholar][Crossref]
  2. Allen SJ, Martinez EG, Gregorio GV, Dans LF. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev. 2010;(11):CD003048. [Google Scholar][Crossref]
  3. Collinson S, Deans A, Padua-Zamora A, Gregorio GV, Li C, Dans LF, et al. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev. 2020;(12):CD003048. [Google Scholar][Crossref]
  4. Goldenberg JZ, Ma SS, Saxton JD, Martzen MR, Vandvik PO, Thorlund K, et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev. 2013;(5):CD006095. [Google Scholar][Crossref]
  5. McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic-associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol. 2006;101(4):812-22. [Google Scholar][Crossref]
  6. Szajewska H, Kołodziej M. Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Aliment Pharmacol Ther. 2015;42(7):793-801. [Google Scholar][Crossref]
  7. Szajewska H, Skórka A, Ruszczyński M, Gieruszczak-Białek D. Meta-analysis: Lactobacillus GG for treating acute gastroenteritis in children—updated analysis of randomised controlled trials. Aliment Pharmacol Ther. 2013;38(5):467-76. [Google Scholar][Crossref]
  8. Schnadower D, Tarr PI, Casper TC, Gorelick MH, Dean JM, O'Connell KJ, et al. Lactobacillus rhamnosus GG versus placebo for acute gastroenteritis in children. N Engl J Med. 2018;379(21):2002-14. [Google Scholar][Crossref]
  9. Freedman SB, Williamson-Urquhart S, Farion KJ, Gouin S, Willan AR, Poonai N, et al. Multicenter trial of a combination probiotic for children with gastroenteritis. N Engl J Med. 2018;379(21):2015-26. [Google Scholar][Crossref]
  10. Guarino A, Ashkenazi S, Gendrel D, Lo Vecchio A, Shamir R, Szajewska H. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: update 2014. J Pediatr Gastroenterol Nutr. 2014;59(1):132-52. [Google Scholar][Crossref]
  11. Su GL, Ko CW, Bercik P, Falck-Ytter Y, Sultan S, Weizman AV, et al. AGA clinical practice guidelines on the role of probiotics in the management of gastrointestinal disorders. Gastroenterology. 2020;159(2):697-705. [Google Scholar][Crossref]
  12. Lv Z, Wang B, Zhou X, Wang F, Xie Y, Zheng H, et al. Efficacy and safety of probiotics as adjuvant agents for Helicobacter pylori infection: a meta-analysis. Exp Ther Med. 2015;9(3):707-16. [Google Scholar][Crossref]
  13. McFarland LV. Meta-analysis of probiotics for the prevention of traveler's diarrhea. Travel Med Infect Dis. 2007;5(2):97-105. International Journal of Medical and All Body Health Research www.allmedicaljournal.com [Google Scholar][Crossref]
  14. Plaza-Diaz J, Ruiz-Ojeda FJ, Gil-Campos M, Gil A. Mechanisms of action of probiotics. Adv Nutr. 2019;10(Suppl 1):S49-66. [Google Scholar][Crossref]
  15. Bermudez-Brito M, Plaza-Díaz J, Muñoz-Quezada S, Gómez-Llorente C, Gil A. Probiotic mechanisms of action. Ann Nutr Metab. 2012;61(2):160-74. [Google Scholar][Crossref]

How to Cite

Kaushik, P., Srinivas, J., Saxena, R., & Jr, P. (2026). Probiotic Use in Gastrointestinal (G.I.T.) Infections. International Journal of Medical and All Body Health Research, 7(3), 61-65. https://doi.org/10.54660/IJMBHR.2026.7.3.61-65

Kaushik, Pradyuman, et al. "Probiotic Use in Gastrointestinal (G.I.T.) Infections." International Journal of Medical and All Body Health Research, vol. 7, no. 3, 2026, pp. 61-65. https://doi.org/10.54660/IJMBHR.2026.7.3.61-65.

Kaushik, P., Srinivas, J., Saxena, R. and Jr, P. (2026) 'Probiotic Use in Gastrointestinal (G.I.T.) Infections', International Journal of Medical and All Body Health Research, 7(3), pp. 61-65. doi: 10.54660/IJMBHR.2026.7.3.61-65.

Kaushik P, Srinivas J, Saxena R, Jr P. Probiotic Use in Gastrointestinal (G.I.T.) Infections. International Journal of Medical and All Body Health Research. 2026;7(3):61-65. doi:10.54660/IJMBHR.2026.7.3.61-65

Similar Articles

Share

Find this Article on

Google Scholar Semantic Scholar OpenAlex Scilit Crossref ResearchGate BASE

A newly published article may take a few days to appear on these services.